Search Tag: Immuno-Oncology
HaemaLogiX strengthens Board with appointment of Dr. Geoff Nichol
2022 07 Jul
Dr. Geoff Nichol, M.B., Ch.B., M.B.A., joins HaemaLogiX’s Board of Directors as Non-Executive Director, bringing nearly 30 years of global drug development experience Past achievements include approval of Augmentin BID for adults and children, plus foundational clinical development of breakthrough cancer immunotherapy checkpoint inhibitors, Yervoy... Read more
15th Annual Biomarker World Congress 2019
2019 17 Jun
Find Cambridge Healthtech Institute on Social Media Read more